Fazadinium in anaesthesia.
暂无分享,去创建一个
[1] D. Scott,et al. Fazadinium--a new formulation. , 1977, British journal of anaesthesia.
[2] Schuh Ft. Clinical neuromuscular pharmacology of AH 8165 D, an azobis-arylimidazo-pyridinium-compound. , 1975 .
[3] F. Schuh. Clinical neuromuscular pharmacology of AH 8165 D, an azobis-arylimidazo-pyridinium-compound. , 1975, Der Anaesthesist.
[4] J. Dundee,et al. Proceedings: Tracheal intubation using AH8165: a comparison with suxamethonium. , 1974, British journal of anaesthesia.
[5] T. M. Savege,et al. The cardiovascular effects of AH 8165 , 1973, Anaesthesia.
[6] J. Dundee,et al. Initial clinical experience with AH 8165D, a new rapidly acting nondepolarizing muscle relaxant. , 1973, Anaesthesia.
[7] Tomlin Pj. The respiratory effects of Althesin. , 1972 .
[8] J. Dundee,et al. Some aspects of the clinical pharmacology of Althesin. , 1972, Postgraduate medical journal.
[9] B. O'Connor. Conclusions—and a proposed pattern for re-organization , 1972 .
[10] T. M. Savege,et al. An azobis-arylimidazo-pyridinium derivative: a rapidly acting non-depolarising muscle-relaxant. Clinical study. , 1972, Lancet.
[11] P. Tomlin. The respiratory effects of Althesin. , 1972, Postgraduate medical journal.
[12] A. T. Birmingham,et al. A comparison of the effect of induction of anaesthesia by thiopentone or Althesin on the duration of action of suxamethonium. , 1972, Postgraduate medical journal.
[13] J. P. Currie,et al. THE PHARMACOLOGICAL PROPERTIES IN ANIMALS OF CT1341—A NEW STEROID ANAESTHETIC AGENT , 1972, British journal of anaesthesia.
[14] Rd Dripps,et al. New classification of physical status , 1963 .